{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:16:05Z","timestamp":1788869765107,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Children with rheumatologic diseases often require immunosuppressive therapies, which can compromise their immune response and increase susceptibility to infections. Despite the heightened risk, vaccination coverage in this population is frequently suboptimal, largely due to concerns over vaccine safety, especially live attenuated vaccines, and the absence of clear, universally adopted guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This retrospective study aims to evaluate the vaccination status and serological immunity of pediatric patients with rheumatologic diseases at the time of diagnosis, prior to initiation of immunosuppressive therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective review of medical records from children under 16 years of age diagnosed with a rheumatologic disease at Geneva University Hospitals (HUG) between 2005 and 2023. Demographic data, clinical diagnosis, vaccination history, and available vaccine-specific serologies were collected and analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy-four patients were included, with a median age at diagnosis of 6 years. At the time of diagnosis, vaccination coverage was highest for\n                      <jats:italic>Haemophilus influenzae<\/jats:italic>\n                      type b (Hib; 93%), followed by diphtheria and tetanus (91%), measles-mumps-rubella (MMR; 80%), pertussis and poliomyelitis (77\u201378%), pneumococcus (77%), varicella-zoster virus (VZV; 72%), and hepatitis B virus (HBV; 64%). Baseline serological testing was available in only half of the patients (38\/74, 51%). Among those tested, seroprotection was highest for Hib (100%), followed by tetanus (91%), measles (89%), diphtheria (88%), hepatitis B (58%), varicella (47%), and pneumococcus (42%). Longitudinal follow-up revealed limited and inconsistent serological monitoring, with only a minority of patients undergoing repeat testing, and very few receiving booster vaccinations, despite the generally stable protection levels observed over time.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vaccination coverage in children with rheumatologic diseases remains suboptimal, particularly for varicella, hepatitis B, and pneumococcus. These findings underscore the critical importance of optimizing vaccination coverage at diagnosis and establishing systematic serologic surveillance protocols in this high-risk population, rather than relying solely on vaccine history.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-026-01240-5","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:25:12Z","timestamp":1782213912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vaccination coverage and serological follow-up in children with rheumatologic diseases: a retrospective single-centre study"],"prefix":"10.1186","volume":"24","author":[{"given":"Ilias","family":"Grafas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-4574","authenticated-orcid":false,"given":"Laure F.","family":"Pittet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5992-9540","authenticated-orcid":false,"given":"Manel","family":"Mejbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9974-2172","authenticated-orcid":false,"given":"Geraldine","family":"Blanchard-Rohner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"5","key":"1240_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40272-014-0084-2","volume":"16","author":"F Nuti","year":"2014","unstructured":"Nuti F, Civitelli F, Cucchiara S. Long-term safety of immunomodulators in pediatric inflammatory diseases. Pediatr Drugs. 2014;16(5):343\u201352. https:\/\/doi.org\/10.1007\/s40272-014-0084-2.","journal-title":"Pediatr Drugs"},{"issue":"6","key":"1240_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40884","volume":"71","author":"S Ringold","year":"2019","unstructured":"Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology\/arthritis Foundation Guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic Polyarthritis, sacroiliitis, and enthesitis. Arthritis Rheumatol. 2019;71(6):846\u201363. https:\/\/doi.org\/10.1002\/art.40884.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"1240_CR3","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheumatism. 2012;64(8):2773\u201380. https:\/\/doi.org\/10.1002\/art.34458.","journal-title":"Arthritis Rheumatism"},{"issue":"5","key":"1240_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11926-013-0327-1","volume":"15","author":"A Hurd","year":"2013","unstructured":"Hurd A, Beukelman T. Infectious complications in juvenile idiopathic arthritis. Curr Rheumatol Rep. 2013;15(5):327. https:\/\/doi.org\/10.1007\/s11926-013-0327-1.","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"1240_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.cmi.2023.04.001","volume":"29","author":"T Schober","year":"2023","unstructured":"Schober T, Morris SK, Bettinger JA, Bancej C, Burton C, Foo C, et al. Outcomes of immunocompromised children hospitalized for influenza, 2010-2021, the Canadian immunization monitoring program active (IMPACT). Clin Microbiol Infect. Clin Microbiol Infect. 2023;29(7):924\u201332. https:\/\/doi.org\/10.1016\/j.cmi.2023.04.001.","journal-title":"Clin Microbiol Infect"},{"key":"1240_CR6","doi-asserted-by":"publisher","unstructured":"Simmons AE, Amoako A, Grima AA, Murison KR, Buchan SA, Fisman DN, et al. Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: a retrospective cohort study. PLoS ONE. 2023;18(3):e0283715. https:\/\/doi.org\/10.1371\/journal.pone.0283715.","DOI":"10.1371\/journal.pone.0283715"},{"key":"1240_CR7","doi-asserted-by":"publisher","first-page":"711637","DOI":"10.3389\/fimmu.2021.711637","volume":"12","author":"G Blanchard-Rohner","year":"2021","unstructured":"Blanchard-Rohner G. Vaccination in children with autoimmune disorders and treated with various immunosuppressive regimens: a comprehensive review and practical guide. Front. Immunol. 2021;12:711637. https:\/\/doi.org\/10.3389\/fimmu.2021.711637.","journal-title":"Front. Immunol"},{"issue":"2","key":"1240_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.autrev.2011.08.010","volume":"11","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, Ott de Bruin LM, Borrow R, van der Klis F, Kon\u00e9-Paut I, Fasth A, et al. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations. Autoimmun Rev. 2011;11(2):112\u201322. https:\/\/doi.org\/10.1016\/j.autrev.2011.08.010.","journal-title":"Autoimmun Rev"},{"key":"1240_CR9","doi-asserted-by":"publisher","first-page":"910026","DOI":"10.3389\/fped.2022.910026","volume":"10","author":"MH Jansen","year":"2022","unstructured":"Jansen MH, Rondaan C, Legger G, Minden K, Uziel Y, Toplak N, et al. Efficacy, immunogenicity and safety of vaccination in pediatric patients with autoimmune inflammatory rheumatic diseases (pedAIIRD): a systematic literature review for the 2021 update of the EULAR\/PRES recommendations. Front Pediatr. 2022;10:910026. https:\/\/doi.org\/10.3389\/fped.2022.910026.","journal-title":"Front Pediatr"},{"key":"1240_CR10","unstructured":"Jansen MHA, et al. EULAR\/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheum Dis. 2022."},{"issue":"23","key":"1240_CR11","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1001\/jama.2013.6768","volume":"309","author":"MW Heijstek","year":"2013","unstructured":"Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S, de Vries LD, et al. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA. 2013;309(23):2449\u201356. https:\/\/doi.org\/10.1001\/jama.2013.6768.","journal-title":"JAMA"},{"issue":"9","key":"1240_CR12","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.vaccine.2020.01.037","volume":"38","author":"Y Uziel","year":"2020","unstructured":"Uziel Y, Moshe V, Onozo B, Kulcs\u00e1r A, Tr\u00f3bert-Sipos D, Akikusa JD, et al. Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: multicenter, retrospective data collection. Vaccine. 2020;38(9):2198\u2013201. https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.037.","journal-title":"Vaccine"},{"issue":"7","key":"1240_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11926-020-00905-8","volume":"22","author":"N Toplak","year":"2020","unstructured":"Toplak N, Uziel Y. Vaccination for children on biologics. Curr Rheumatol Rep. 2020;22(7):26. https:\/\/doi.org\/10.1007\/s11926-020-00905-8.","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"1240_CR14","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/rheumatology\/kes175","volume":"51","author":"MP Morin","year":"2012","unstructured":"Morin MP, Quach C, Fortin E, Chedeville G. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatol (Oxford). 2012;51(11):2046\u201350. https:\/\/doi.org\/10.1093\/rheumatology\/kes175.","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"1240_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12969-021-00594-2","volume":"19","author":"MM Kostik","year":"2021","unstructured":"Kostik MM, Lubimova NA, Fridman IV, Goleva OV, Kharit SM. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary centre study. Pediatr Rheumatol Online J. 2021;19(1):108. https:\/\/doi.org\/10.1186\/s12969-021-00594-2.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"1240_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inf"},{"key":"1240_CR17","unstructured":"Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP). Plan de vaccination Suisse 2025. 2025."},{"issue":"6","key":"1240_CR18","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.ajt.2023.12.011","volume":"24","author":"T Gold","year":"2024","unstructured":"Gold T, Gualtieri R, Posfay-Barbe K, Wildhaber BE, McLin V, Blanchard-Rohner G. Assessing vaccine-induced immunity against pneumococcus, hepatitis A and B over a 9-year follow-up in pediatric liver transplant recipients: a nationwide retrospective study. Am J Transpl. 2024;24(6):1070\u201379. https:\/\/doi.org\/10.1016\/j.ajt.2023.12.011.","journal-title":"Am J Transpl"},{"issue":"4","key":"1240_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1128\/CDLI.10.4.514-519.2003","volume":"10","author":"CM Wernette","year":"2003","unstructured":"Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol. Clin Vaccine Immunol. 2003;10(4):514\u201319. https:\/\/doi.org\/10.1128\/CDLI.10.4.514-519.2003.","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"1240_CR20","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1128\/CVI.05158-11","volume":"18","author":"D Goldblatt","year":"2011","unstructured":"Goldblatt D, Ashton L, Zhang Y, Antonello J, Marchese RD. Comparison of a new multiplex binding assay versus the enzyme-linked immunosorbent assay for measurement of serotype-specific pneumococcal capsular polysaccharide IgG. Clin Vaccine Immunol. 2011;18(10):1744\u201351. https:\/\/doi.org\/10.1128\/CVI.05158-11.","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"1240_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1128\/CVI.00415-08","volume":"16","author":"RD Marchese","year":"2009","unstructured":"Marchese RD, Puchalski D, Miller P, Antonello J, Hammond O, Green T, et al. Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum. Clin Vaccine Immunol. 2009;16(3):387\u201396. https:\/\/doi.org\/10.1128\/CVI.00415-08.","journal-title":"Clin Vaccine Immunol"},{"key":"1240_CR22","unstructured":"Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP). Couverture vaccinale en Suisse. 2025."},{"key":"1240_CR23","unstructured":"Zurich CE. Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP). Enqu\u00eate de couverture vaccinale en Suisse. 2019."},{"issue":"1","key":"1240_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12969-025-01174-4","volume":"23","author":"E Sallansonnet","year":"2025","unstructured":"Sallansonnet E, Gualtieri R, Margot H, Mejbri M, Posfay-Barbe K, Blanchard-Rohner G. Vaccination coverage, immune responses, and clinical characteristics in children with PFAPA syndrome: a monocentric prospective study. Pediatr Rheumatol Online J. 2025;23(1):131. https:\/\/doi.org\/10.1186\/s12969-025-01174-4.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"1240_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/INF.0000000000004999","volume":"45","author":"A Hominal","year":"2026","unstructured":"Hominal A, Gualtieri R, Lemaitre B, P\u00f3sfay-Barbe KM, Cao-Van H, Blanchard-Rohner G. Vaccine immunity against pneumococcus in children with cochlear implants. The Pediatr Infect Disease J. 2026;45(2):187\u201393. https:\/\/doi.org\/10.1097\/INF.0000000000004999.","journal-title":"The Pediatr Infect Disease J"},{"key":"1240_CR26","doi-asserted-by":"publisher","first-page":"993811","DOI":"10.3389\/fped.2022.993811","volume":"10","author":"T Welzel","year":"2022","unstructured":"Welzel T, Kuemmerle-Deschner J, Sluka C, Carlomagno R, Cannizzaro Schneider E, Kaiser D, et al. Vaccination completeness in children with rheumatic diseases: a longitudinal, observational multicenter cohort study in Switzerland. Front Pediatr. 2022;10:993811. https:\/\/doi.org\/10.3389\/fped.2022.993811.","journal-title":"Front Pediatr"},{"issue":"1","key":"1240_CR27","first-page":"164","volume":"38","author":"M Bizjak","year":"2020","unstructured":"Bizjak M, Blazina \u0160, Zajc Avramovi\u010d M, Markelj G, Av\u010din T, Toplak N. Vaccination coverage in children with rheumatic diseases. Clin Exp Rheumatol. Clin Exp Rheumatol. 2020;38(1):164\u201370.","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"1240_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/00325481.2023.2287988","volume":"135","author":"\u00d6 Akgun","year":"2023","unstructured":"Akgun \u00d6, Demirkan FG, Kavrul Kayaalp G, Erdemir M, Akay N, \u00c7akmak F, et al. Vaccination coverage of children with rheumatic diseases compared with healthy controls: a retrospective case-control study. Postgrad Med. 2023;135(8):824\u201330. https:\/\/doi.org\/10.1080\/00325481.2023.2287988.","journal-title":"Postgrad Med"},{"issue":"2","key":"1240_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5409\/wjcp.v12.i2.45","volume":"12","author":"E Makarova","year":"2023","unstructured":"Makarova E, Khabirova A, Volkova N, Gabrusskaya T, Ulanova N, Sakhno L, et al. Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: cross-sectional electronic survey data. World J Clin Pediatr. 2023;12(2):45\u201356. https:\/\/doi.org\/10.5409\/wjcp.v12.i2.45.","journal-title":"World J Clin Pediatr"},{"issue":"7","key":"1240_CR30","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s10067-020-05553-y","volume":"40","author":"V Rollet-Cohen","year":"2021","unstructured":"Rollet-Cohen V, Mirete J, Dingulu G, Hofer F, Hofer M, Woerner A, et al. Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the juvenile inflammatory Rheumatism cohort. Clin Rheumatol. 2021;40(7):2855\u201364. https:\/\/doi.org\/10.1007\/s10067-020-05553-y.","journal-title":"Clin Rheumatol"},{"key":"1240_CR31","doi-asserted-by":"publisher","first-page":"956136","DOI":"10.3389\/fped.2022.956136","volume":"10","author":"B Balaziova","year":"2022","unstructured":"Balaziova B, Kukov\u00e1 Z, Mi\u0161\u00edkov\u00e1 D, Novosedl\u00edkov\u00e1 K, Dallos T. Real-life vaccination coverage in Slovak children with rheumatic diseases. Front Pediatr. 2022;10:956136. https:\/\/doi.org\/10.3389\/fped.2022.956136.","journal-title":"Front Pediatr"},{"issue":"10","key":"1240_CR32","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.vaccine.2016.01.027","volume":"34","author":"HM Ingelman-Sundberg","year":"2016","unstructured":"Ingelman-Sundberg HM, Laestadius \u00c5, Chrapkowska C, M\u00f6rdrup K, Magnusson B, Sundberg E, et al. Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-\u03b1 therapy in children with rheumatic diseases: a cross-sectional study. Vaccine. 2016;34(10):1304\u201311. https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.027.","journal-title":"Vaccine"},{"issue":"1","key":"1240_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12969-017-0190-0","volume":"15","author":"MS Camacho-Lovillo","year":"2017","unstructured":"Camacho-Lovillo MS, Bulnes-Ramos A, Goycochea-Valdivia W, Fern\u00e1ndez-Silveira L, N\u00fa\u00f1ez-Cuadros E, Neth O, et al. Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay. Pediatr Rheumatol Online J. 2017;15(1):62. https:\/\/doi.org\/10.1186\/s12969-017-0190-0.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1240_CR34","volume-title":"Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study","author":"N Madelon","year":"2021","unstructured":"Madelon N, et al. Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clin Infect Dis; 2021."},{"issue":"31","key":"1240_CR35","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1016\/j.vaccine.2010.03.080","volume":"28","author":"E Farmaki","year":"2010","unstructured":"Farmaki E, Kanakoudi-Tsakalidou F, Spoulou V, Trachana M, Pratsidou-Gertsi P, Tritsoni M, et al. The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis. Vaccine. 2010;28(31):5109\u201313. https:\/\/doi.org\/10.1016\/j.vaccine.2010.03.080.","journal-title":"Vaccine"},{"key":"1240_CR36","doi-asserted-by":"publisher","unstructured":"Jensen L, Christensen AE, Nielsen S, Pedersen FK, Rosth\u00f8j S, J\u00f8rgensen CS, et al. Response to pneumococcal conjugate and polysaccharide vaccination in children with rheumatic disease. Scand J Immunol. 2022;95(2):e13118. https:\/\/doi.org\/10.1111\/sji.13118.","DOI":"10.1111\/sji.13118"},{"key":"1240_CR37","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.jvacx.2025.100663","volume":"25","author":"M Bizjak","year":"2025","unstructured":"Bizjak M, Peterlin J, Av\u010din T, Petrovec M, Ihan A, Zajc Avramovi\u010d M, et al. Safety, long-term effectiveness, and immunogenicity of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy. Vaccine. 2025;25:100663. https:\/\/doi.org\/10.1016\/j.jvacx.2025.100663","journal-title":"Vaccine:X"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01240-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01240-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01240-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:02:42Z","timestamp":1788868962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-026-01240-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01240-5","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Was obtained from the local ethical committee (No: CCER 2020\u201301537).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed written consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}